RE:Shareholders brainstorming financing? Yeah, Right.I think to say that Telesta has no negotiating power with potential partners is wrong. If there were only one interested party then yes that interested party could potentially wait until Telesta is running low on funds and make them squirm. The update did not say that there was only one interested party but several. That completely changes the game. The update also said that the market assessment that they were waiting for not only confirmed the potential US market but doubled it to $400 mil. That is just the US market.Remember, according the the new web site, they will be attending Bio-Europe March 9, 2015.
Make no mistake Telesta is in the driver’s seat in terms of negotiations. This is exactly what large drug companies are looking for. Partnering or buying Telesta saves them 10-15 years of product development. Remember Endo spent around 100 mil on a partnership and faulty trial. How much more is Telesta worth with MCNA, a drug that will be submitted for FDA approval by the end of June? In my opinion every day Telesta gets closer to submitting to FDA for approval the price for partnership or buyout goes up.